129 related articles for article (PubMed ID: 38926284)
1. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells.
Wang Q; Aliyu L; Chung CY; Rosenberg JN; Yu G; Betenbaugh MJ
Methods Mol Biol; 2024; 2810():249-271. PubMed ID: 38926284
[TBL] [Abstract][Full Text] [Related]
2. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells.
Wang Q; Chung CY; Rosenberg JN; Yu G; Betenbaugh MJ
Methods Mol Biol; 2018; 1850():237-257. PubMed ID: 30242691
[TBL] [Abstract][Full Text] [Related]
3. FX knockout CHO hosts can express desired ratios of fucosylated or afucosylated antibodies with high titers and comparable product quality.
Louie S; Haley B; Marshall B; Heidersbach A; Yim M; Brozynski M; Tang D; Lam C; Petryniak B; Shaw D; Shim J; Miller A; Lowe JB; Snedecor B; Misaghi S
Biotechnol Bioeng; 2017 Mar; 114(3):632-644. PubMed ID: 27666939
[TBL] [Abstract][Full Text] [Related]
4. Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells.
Grav LM; la Cour Karottki KJ; Lee JS; Kildegaard HF
Methods Mol Biol; 2017; 1603():101-118. PubMed ID: 28493126
[TBL] [Abstract][Full Text] [Related]
5. Double knockdown of alpha1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC.
Imai-Nishiya H; Mori K; Inoue M; Wakitani M; Iida S; Shitara K; Satoh M
BMC Biotechnol; 2007 Nov; 7():84. PubMed ID: 18047682
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking β-1,2-xylose and core α-1,3-fucose.
Jansing J; Sack M; Augustine SM; Fischer R; Bortesi L
Plant Biotechnol J; 2019 Feb; 17(2):350-361. PubMed ID: 29969180
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics.
Kanda Y; Imai-Nishiya H; Kuni-Kamochi R; Mori K; Inoue M; Kitajima-Miyama K; Okazaki A; Iida S; Shitara K; Satoh M
J Biotechnol; 2007 Jun; 130(3):300-10. PubMed ID: 17559959
[TBL] [Abstract][Full Text] [Related]
8. Accelerated generation of gene-engineered monoclonal CHO cell lines using FluidFM nanoinjection and CRISPR/Cas9.
Antony JS; Herranz AM; Mohammadian Gol T; Mailand S; Monnier P; Rottenberger J; Roig-Merino A; Keller B; Gowin C; Milla M; Beyer TA; Mezger M
Biotechnol J; 2024 Apr; 19(4):e2300505. PubMed ID: 38651269
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies.
Malphettes L; Freyvert Y; Chang J; Liu PQ; Chan E; Miller JC; Zhou Z; Nguyen T; Tsai C; Snowden AW; Collingwood TN; Gregory PD; Cost GJ
Biotechnol Bioeng; 2010 Aug; 106(5):774-83. PubMed ID: 20564614
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation.
Byrne G; O'Rourke SM; Alexander DL; Yu B; Doran RC; Wright M; Chen Q; Azadi P; Berman PW
PLoS Biol; 2018 Aug; 16(8):e2005817. PubMed ID: 30157178
[TBL] [Abstract][Full Text] [Related]
11. Accelerating genome editing in CHO cells using CRISPR Cas9 and CRISPy, a web-based target finding tool.
Ronda C; Pedersen LE; Hansen HG; Kallehauge TB; Betenbaugh MJ; Nielsen AT; Kildegaard HF
Biotechnol Bioeng; 2014 Aug; 111(8):1604-16. PubMed ID: 24827782
[TBL] [Abstract][Full Text] [Related]
12. CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering.
Glinšek K; Bozovičar K; Bratkovič T
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175850
[TBL] [Abstract][Full Text] [Related]
13. Producing defucosylated antibodies with enhanced in vitro antibody-dependent cellular cytotoxicity via
Zong H; Han L; Ding K; Wang J; Sun T; Zhang X; Cagliero C; Jiang H; Xie Y; Xu J; Zhang B; Zhu J
Eng Life Sci; 2017 Jul; 17(7):801-808. PubMed ID: 32624826
[TBL] [Abstract][Full Text] [Related]
14. Production of afucosylated antibodies in CHO cells by coexpression of an anti-FUT8 intrabody.
Joubert S; Guimond J; Perret S; Malenfant F; Elahi SM; Marcil A; Parat M; Gilbert M; Lenferink AEG; Baardsnes J; Durocher Y
Biotechnol Bioeng; 2022 Aug; 119(8):2206-2220. PubMed ID: 35509261
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-Mediated Knockout of MicroRNA-744 Improves Antibody Titer of CHO Production Cell Lines.
Raab N; Mathias S; Alt K; Handrick R; Fischer S; Schmieder V; Jadhav V; Borth N; Otte K
Biotechnol J; 2019 May; 14(5):e1800477. PubMed ID: 30802343
[TBL] [Abstract][Full Text] [Related]
16. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ
Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616
[TBL] [Abstract][Full Text] [Related]
17. Generation of FX
Liu W; Padmashali R; Monzon OQ; Lundberg D; Jin S; Dwyer B; Lee YJ; Korde A; Park S; Pan C; Zhang B
Biotechnol Prog; 2021 Jan; 37(1):e3061. PubMed ID: 32748555
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas13d for Gene Knockdown and Engineering of CHO Cells.
Shen CC; Lin MW; Nguyen BKT; Chang CW; Shih JR; Nguyen MTT; Chang YH; Hu YC
ACS Synth Biol; 2020 Oct; 9(10):2808-2818. PubMed ID: 32911927
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas12a-mediated CHO genome engineering can be effectively integrated at multiple stages of the cell line generation process for bioproduction.
Schweickert PG; Wang N; Sandefur SL; Lloyd ME; Konieczny SF; Frye CC; Cheng Z
Biotechnol J; 2021 Apr; 16(4):e2000308. PubMed ID: 33369118
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
